Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly Launches Lantus Biosimilar To Boost Sales, But Not Without Risks
Eli Lilly Launches Lantus Biosimilar To Boost Sales, But Not Without Risks
Eli Lilly Launches Lantus Biosimilar To Boost Sales, But Not Without Risks
Submitted by
admin
on June 28, 2016 - 5:33pm
Source:
Seeking Alpha
News Tags:
Eli Lilly
Lantus
biosimilars
diabetes
Basaglar
Headline:
Eli Lilly Launches Lantus Biosimilar To Boost Sales, But Not Without Risks
Do Not Allow Advertisers to Use My Personal information
